Abstract | BACKGROUND: METHODS: We report a case of malignant catatonia in a patient diagnosed with DPHL that was refractory to electroconvulsive therapy (ECT) and review the literature on catatonia in DPHL. RESULTS: DISCUSSION: No treatment for DPHL has been proven to be widely effective. Hyperbaric oxygen treatments may reduce the rate of development, and symptom improvement has been reported with stimulants and other psychotropic agents. Review of literature reveals rare success with GABAergic agents for catatonia after cerebral hypoxia and no cases successfully treated with ECT. There are 7 case reports of neurologic decompensation during ECT treatment after a cerebral hypoxic event. CONCLUSION: Caution is advised when considering ECT for catatonia when delayed sequelae of cerebral hypoxia are on the differential diagnosis, as there is a dearth of evidence to support this treatment approach.
|
Authors | Davin K Quinn, Christopher C Abbott |
Journal | Psychosomatics
(Psychosomatics)
2014 Nov-Dec
Vol. 55
Issue 6
Pg. 525-35
ISSN: 1545-7206 [Electronic] England |
PMID | 25262046
(Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
|
Copyright | Copyright © 2014 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Central Nervous System Stimulants
- Methylphenidate
- Amantadine
- Lorazepam
|
Topics |
- Amantadine
(therapeutic use)
- Brain
(pathology)
- Catatonia
(drug therapy, etiology, pathology, therapy)
- Central Nervous System Stimulants
(therapeutic use)
- Electroconvulsive Therapy
- Female
- Humans
- Hypoxia, Brain
(complications)
- Leukoencephalopathies
(drug therapy, etiology, pathology, therapy)
- Lorazepam
(therapeutic use)
- Magnetic Resonance Imaging
- Methylphenidate
(therapeutic use)
- Middle Aged
- Neuroimaging
- Treatment Failure
|